Aquisição de FARICIMAB IVI 120MG/ML 0,24ML SOL INJ, ao Lab. Roche, para a ULSASI, para o ano 2024

ID 10917649 · Portal BASE
Price
Base Price
€145,380 .00
Effective Price
€87,290 .00 -40.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Amadora
Bidder Count
—
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Dates
Publication
12 Sep 2024
Celebration
12 Sep 2024
Contracting Entity
HOSPITAL PROFESSOR DOUTOR FERNANDO FONSECA, EPE
NIF 503035416
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 35 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
145380.0
Threshold
150000.0
Rule
A5 threshold splitting: price within 5% below 150000.0
Detected 2026-03-06